phosphatidylcholines has been researched along with tacrolimus in 5 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (tacrolimus) | Trials (tacrolimus) | Recent Studies (post-2010) (tacrolimus) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 17,757 | 2,319 | 6,661 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | tacrolimus (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 7.18 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.58 | |
| Cytochrome P450 3A5 | Homo sapiens (human) | 0.385 | |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0021 | |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | 0.2547 | |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Homo sapiens (human) | 0.0148 | |
| Splicing factor 3B subunit 3 | Homo sapiens (human) | 0.0123 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 3.3 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ruetz, S | 1 |
| Ishii, T; Kai, T; Kawano, K; Kim, YI; Kobayashi, M; Tatsuma, T | 1 |
| Kawashima, T; Kuroda, T; Matsuzawa, Y; Nishide, T; Shirai, K; Wakabayashi, T | 1 |
| Betageri, GV; Nekkanti, V; Rueda, J; Wang, Z | 1 |
| Chen, Y; Jin, Q; Liu, J; Lv, Q; Sun, Z; Wang, G; Wang, J; Xie, M; Yang, Y; Zhang, L | 1 |
5 other study(ies) available for phosphatidylcholines and tacrolimus
| Article | Year |
|---|---|
Yeast secretory vesicle system for expression and functional characterization of P-glycoproteins.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Biological Transport; Carrier Proteins; Cloning, Molecular; Cytoplasmic Granules; DNA, Complementary; Drug Resistance, Multiple; Kinetics; Membrane Proteins; Mice; Phosphatidylcholines; Recombinant Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Tacrolimus; Transformation, Genetic; Vesicular Transport Proteins | 1998 |
Immunodepressants ameliorate normothermic ischemia injury to the rat liver by down-regulating tumor necrosis factor, not by alleviation of lipid peroxidative injury.
Topics: Alanine Transaminase; Animals; Azathioprine; Cyclosporine; Female; Immunosuppressive Agents; Ischemia; Lipid Peroxidation; Liver; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tacrolimus; Temperature; Time Factors; Tumor Necrosis Factor-alpha | 1994 |
Lecithinized superoxide dismutase treatment improves steroid-refractory interstitial pneumonia.
Topics: Adrenal Cortex Hormones; Cyclosporine; Dermatomyositis; Exercise Tolerance; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged; Mucin-1; Phosphatidylcholines; Prednisolone; Pulmonary Fibrosis; Radiography; Respiratory Function Tests; Superoxide Dismutase; Tacrolimus; Treatment Outcome | 2010 |
Design, Characterization, and In Vivo Pharmacokinetics of Tacrolimus Proliposomes.
Topics: Administration, Oral; Animals; Biological Availability; Chemistry, Pharmaceutical; Drug Carriers; Lipids; Liposomes; Male; Membranes, Artificial; Particle Size; Permeability; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Solubility; Tacrolimus | 2016 |
Improving acute cardiac transplantation rejection therapy using ultrasound-targeted FK506-loaded microbubbles in rats.
Topics: Animals; Drug Carriers; Drug Liberation; Feasibility Studies; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Male; Microbubbles; Myocardium; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Rats; Tacrolimus; Ultrasonography | 2019 |